This study provides the first demonstration that CNP inhibits L-type Ca2+ current in atrial myocytes by binding to the NPR-C receptor, likely via decreased adenylyl cyclase activity.
Answers are grounded in this paper and cite their sources.
Does not inform clinical arrhythmia management; leaves open CNP-NPR-C effects on human atrial electrophysiology.
Single atrial myocytes were isolated from the bullfrog heart and studied under current and voltage clamp conditions to determine the electrophysiological effects of the C-type natriuretic peptide (CNP). CNP (10(-8) M) significantly shortened the action potential and reduced its peak amplitude after the application of isoproteronol (10(-7) M). In voltage clamp studies, CNP inhibited isoproteronol-stimulated L-type Ca2+ current (ICa) without any significant effect on the inward rectifier K+ current. The effects of cANF (10(-8) M), a selective agonist of the natriuretic peptide C receptor (NPR-C), were very similar to those of CNP. Moreover, HS-142-1, an antagonist of the guanylyl cyclase-linked NPR-A and NPR-B receptors did not alter the inhibitory effect of CNP on ICa. Inclusion of cAMP in the recording pipette to stimulate ICa at a point downstream from adenylyl cyclase increased ICa, but this effect was not inhibited by cANF. These results provide the first demonstration that CNP can inhibit ICa after binding to NPR-C, and suggest that this inhibition involves a decrease in adenylyl cyclase activity, which leads to reduced intracellular levels of cAMP.
No takes yet. Share an insight, caveat, or question.
Rose et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: